InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Beyer Russell P, Chief Financial Officer. Director active across 1 companies, notably SAB Biotherapeutics, Inc.. In total, 2 filings have been logged. The latest transaction was filed on 18 October 2021 — Attribution. Regulator: SEC (Form 4). All data is openly available.
Declarations2 total
€21,5242,475 shares@ €8.6965100.0% of flow
Common Stock
SEC:0001493152-21-028917·
€21,5242,475 shares@ €8.696550.0% of flow
Common Stock
SEC:0001493152-21-028917:0·
2 of 2 declarations
About Beyer Russell P
Russell P. Beyer is the Chief Financial Officer at SAB Biotherapeutics, Inc. He oversees the financial operations of the company, including budgeting and financial reporting. His role is essential in ensuring the financial health and growth of SAB Biotherapeutics.
